Catalio Capital Management Closes $400M+ Fund IV to Fuel Breakthrough Biomedical Innovation

What You Should Know:  – Catalio Capital Management, LP (“Catalio”), a healthcare investment firm, today announced the successful close of its fourth venture fund, Catalio Nexus Fund IV (“Fund IV”), with over $400M in commitments across the Fund and its related co-investment vehicles.  – Launched in 2020 by Co-Founders George Petrocheilos and Dr. J...

• Published date: 01-07-2025 02:00 PM